These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 38195035

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mettl3-mediated m6A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration.
    Jiang FQ, Liu K, Chen JX, Cao Y, Chen WY, Zhao WL, Song GH, Liang CQ, Zhou YM, Huang HL, Huang RJ, Zhao H, Park KS, Ju Z, Cai D, Qi XF.
    Elife; 2022 Nov 18; 11():. PubMed ID: 36399125
    [Abstract] [Full Text] [Related]

  • 4. METTL3-mediated m6A modification increases Hspa1a stability to inhibit osteoblast aging.
    Wang Y, Chen Y, Xiao H, Liu Z, Liu X, Feng Z, Sheng X, Peng B, Ren X, Xu L, Teng F, Yi Z, Niu Y, Xiang D, Xia Y, Geng B.
    Cell Death Discov; 2024 Mar 27; 10(1):155. PubMed ID: 38538596
    [Abstract] [Full Text] [Related]

  • 5. METTL3 mediates osteoblast apoptosis by regulating endoplasmic reticulum stress during LPS-induced inflammation.
    Kong Y, Zhang Y, Cai Y, Li D, Yi B, Xu Q.
    Cell Signal; 2022 Jul 27; 95():110335. PubMed ID: 35461899
    [Abstract] [Full Text] [Related]

  • 6. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, Li C, Sun L, Qin J, Xu T, He B, Pan Y, Sun H, Wang S.
    Mol Cancer; 2020 Jun 17; 19(1):106. PubMed ID: 32552762
    [Abstract] [Full Text] [Related]

  • 7. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J, Xie H, Ying Y, Chen H, Yan H, He L, Xu M, Xu X, Liang Z, Liu B, Wang X, Zheng X, Xie L.
    Mol Cancer; 2020 Oct 29; 19(1):152. PubMed ID: 33121495
    [Abstract] [Full Text] [Related]

  • 8. m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.
    Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, Di W, Hu B, An J, Kong L, Pan L, Su G.
    J Hematol Oncol; 2019 Dec 09; 12(1):135. PubMed ID: 31818312
    [Abstract] [Full Text] [Related]

  • 9. METTL3 Regulates Osteoblast Differentiation and Inflammatory Response via Smad Signaling and MAPK Signaling.
    Zhang Y, Gu X, Li D, Cai L, Xu Q.
    Int J Mol Sci; 2019 Dec 27; 21(1):. PubMed ID: 31892163
    [Abstract] [Full Text] [Related]

  • 10. METTL3-Mediated lncRNA m6A Modification in the Osteogenic Differentiation of Human Adipose-Derived Stem Cells Induced by NEL-Like 1 Protein.
    Song Y, Pan Y, Wu M, Sun W, Luo L, Zhao Z, Liu J.
    Stem Cell Rev Rep; 2021 Dec 27; 17(6):2276-2290. PubMed ID: 34505967
    [Abstract] [Full Text] [Related]

  • 11. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.
    Liu L, Wu Y, Li Q, Liang J, He Q, Zhao L, Chen J, Cheng M, Huang Z, Ren H, Chen J, Peng L, Gao F, Chen D, Wang A.
    Mol Ther; 2020 Oct 07; 28(10):2177-2190. PubMed ID: 32621798
    [Abstract] [Full Text] [Related]

  • 12. METTL3 enhances dentinogenesis differentiation of dental pulp stem cells via increasing GDF6 and STC1 mRNA stability.
    Pan Y, Liu Y, Cui D, Yu S, Zhou Y, Zhou X, Du W, Zheng L, Wan M.
    BMC Oral Health; 2023 Apr 11; 23(1):209. PubMed ID: 37041485
    [Abstract] [Full Text] [Related]

  • 13. METTL3's role in cervical cancer development through m6A modification.
    Liu Y, Li C, Deng Q, Ren X, Wang H.
    FASEB J; 2024 Jun 15; 38(11):e23693. PubMed ID: 38809685
    [Abstract] [Full Text] [Related]

  • 14. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
    Zhang X, Hao H, Ma L, Zhang Y, Hu X, Chen Z, Liu D, Yuan J, Hu Z, Guan W.
    mBio; 2021 Aug 31; 12(4):e0106721. PubMed ID: 34225491
    [Abstract] [Full Text] [Related]

  • 15. Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating patched homolog 1 via N6-methyladenosine methylation.
    Liang H, Fang C, Zhang L.
    Am J Physiol Cell Physiol; 2023 Sep 01; 325(3):C770-C779. PubMed ID: 37575058
    [Abstract] [Full Text] [Related]

  • 16. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM, Qi FF, Wang J, Duan YY, Zhao LL, Wang YD, Zhang TC, Liao XH.
    Int J Mol Sci; 2022 Jun 09; 23(12):. PubMed ID: 35742899
    [Abstract] [Full Text] [Related]

  • 17. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma.
    Chai RC, Chang YZ, Chang X, Pang B, An SY, Zhang KN, Chang YH, Jiang T, Wang YZ.
    J Hematol Oncol; 2021 Jul 10; 14(1):109. PubMed ID: 34246306
    [Abstract] [Full Text] [Related]

  • 18. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
    Li X, Jin J, Long X, Weng R, Xiong W, Liang J, Liu J, Sun J, Cai X, Zhang L, Liu Y.
    Reprod Biol Endocrinol; 2023 Oct 27; 21(1):99. PubMed ID: 37891533
    [Abstract] [Full Text] [Related]

  • 19. METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export.
    Li D, Cai L, Meng R, Feng Z, Xu Q.
    Int J Mol Sci; 2020 Feb 28; 21(5):. PubMed ID: 32121289
    [Abstract] [Full Text] [Related]

  • 20. METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma.
    Wu Y, Chang N, Zhang Y, Zhang X, Xu L, Che Y, Qiao T, Wu B, Zhou Y, Jiang J, Xiong J, Zhang J, Zhang J.
    J Exp Clin Cancer Res; 2021 Mar 06; 40(1):90. PubMed ID: 33676554
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.